Pioglitazone--where do we stand in India?

J Assoc Physicians India. 2012 Jan:60:68-70.
No abstract available

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • India
  • Insulin Resistance
  • Pioglitazone
  • Risk Assessment
  • Thiazolidinediones / adverse effects*
  • Time Factors
  • Urinary Bladder Neoplasms / chemically induced*

Substances

  • Thiazolidinediones
  • Pioglitazone